Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Syndax Pharmaceuticals
SNDX
$1.69B
| $20.7M | 0.01% |
981,886
+18,550
| +2% | +$461K |
|
827
ARK Innovation ETF
ARKK
$5.64B
| $20.7M | 0.01% |
513,749
-14,084
| -3% | -$540K |
|
828
PUT
Five Below
FIVE
$12B
| $20.6M | 0.01% |
100,000
+70,000
| +233% | +$13.8M |
|
829
Trimble
TRMB
$13.2B
| $20.6M | 0.01% |
392,884
-46,368
| -11% | -$2.47M |
|
830
PUT
Gilead Sciences
GILD
$162B
| $20.5M | 0.01% |
+247,600
| New | +$20.5M |
|
831
Coty
COTY
$2.42B
| $20.5M | 0.01% |
1,699,376
+530,922
| +45% | +$5.62M |
|
832
Trip.com Group
TCOM
$29.6B
| $20.5M | 0.01% |
543,230
-166,253
| -23% | -$6.18M |
|
833
Synchrony
SYF
$24.7B
| $20.4M | 0.01% |
703,188
-724,115
| -51% | -$24.3M |
|
834
PUT
DexCom
DXCM
$32.2B
| $20.4M | 0.01% |
175,500
-3,700
| -2% | -$414K |
|
835
PUT
ON Semiconductor
ON
$31.8B
| $20.3M | 0.01% |
246,800
+151,800
| +160% | +$11.5M |
|
836
Wabtec
WAB
$49.1B
| $20.2M | 0.01% |
199,398
-94,025
| -32% | -$9.6M |
|
|
MRO
837
DELISTED
Marathon Oil Corporation
MRO
| $20.1M | 0.01% |
840,589
-866,832
| -51% | -$22.2M |
|
838
AvalonBay Communities
AVB
$26.5B
| $20.1M | 0.01% |
119,654
-159,098
| -57% | -$27.1M |
|
839
Loews
L
$23.9B
| $20M | 0.01% |
344,131
-131,998
| -28% | -$7.82M |
|
840
FMC
FMC
$1.34B
| $19.9M | 0.01% |
162,660
-43,258
| -21% | -$5.44M |
|
841
MarketAxess Holdings
MKTX
$5.71B
| $19.9M | 0.01% |
50,737
-25,542
| -33% | -$9.04M |
|
842
PUT
Datadog
DDOG
$95.4B
| $19.8M | 0.01% |
272,800
-171,100
| -39% | -$12.6M |
|
|
ISEE
843
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $19.8M | 0.01% |
+813,800
| New | +$17.8M |
|
844
Antero Midstream
AM
$10.4B
| $19.8M | 0.01% |
1,886,901
-600,716
| -24% | -$6.39M |
|
|
845
PUT
Coty
COTY
$2.42B
| $19.7M | 0.01% |
1,635,500
-1,188,100
| -42% | -$12.6M |
|
846
CALL
Cheniere Energy
LNG
$55.2B
| $19.7M | 0.01% |
+125,000
| New | +$18.9M |
|
|
847
PUT
Cheniere Energy
LNG
$55.2B
| $19.7M | 0.01% |
+125,000
| New | +$18.9M |
|
848
iShares Biotechnology ETF
IBB
$9.34B
| $19.6M | 0.01% |
152,041
+149,413
| +5,685% | +$19.6M |
|
849
Entergy
ETR
$50.2B
| $19.4M | 0.01% |
360,802
-125,922
| -26% | -$6.68M |
|
850
PUT
TSMC
TSM
$2.1T
| $19.3M | 0.01% |
207,300
+25,100
| +14% | +$2.25M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.